|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sD76FFD62-3852-11EF-A1B1-89E084CE164B&I=39IZM&T=&OP=Display&O=html&O1=12671071&O2=3880000000005975&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DRetinal%2520amyloid%2520pathology%2520and%2520proof-of-concept%2520imaging%2520trial%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26rft.au%3DBarron%252C%2520Ernesto%26rft.au%3DBiggs%252C%2520David%26rft.au%3DBoyer%252C%2520David%2520S.%26rft.au%3DKoronyo%252C%2520Yosef%26rft.date%3D2017-08-17%26rft.eissn%3D2379-3708%26rft.externalDBID%3DPMC5621887%26rft.genre%3Darticle%26rft.issue%3D16%26rft.jtitle%3DJCI%2520insight%26rft.pub%3DAmerican%2520Society%2520for%2520Clinical%2520Investigation%26rft.volume%3D2%26rft_id%3Dinfo%253Adoi%252F10.1172%252Fjci.insight.93621%26rft_id%3Dinfo%253Apmid%252F28814675%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,4-COBIB_SI_LCL-getHolding-object,5-DOI-getDOI-object,6-REFWORKS_EXPORT_TOOL-getReference-object,7-NCBI_PUBMED_FREE-getCitedRecord-object,8-GOOGLE_SCHOLAR_FREE-getWebSearch-object,9-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=2.207817&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12671071-sD76FFD62-3852-11EF-A1B1-89E084CE164B" timestamp="2024-07-02T11:09:53Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:3880000000005975</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease</jnl:atitle>
<jnl:jtitle>Jci Insight</jnl:jtitle>
<jnl:date>2017-08-17</jnl:date>
<jnl:issn>2379-3708</jnl:issn>
<jnl:volume>2</jnl:volume>
<jnl:issue>16</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2379-3708</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:e9814d4de7ed46dc166d37e51fcd7616854af26a</ctx:identifier>
<ctx:identifier>urn:UUID:sD76FFD62-3852-11EF-A1B1-89E084CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)